| { | |
| "180 Life Sciences Corp.": 51431, | |
| "2invest AG": 51019, | |
| "2seventy bio, Inc.": 51564, | |
| "3-D Matrix, Ltd.": 50795, | |
| "3D Global Biotech Inc.": 51547, | |
| "3SBio Inc.": 50695, | |
| "4D Molecular Therapeutics, Inc.": 51136, | |
| "4D pharma plc": 51098, | |
| "4SC AG": 50415, | |
| "4basebio PLC": 51562, | |
| "89bio, Inc.": 51494, | |
| "ABIONYX Pharma SA": 50687, | |
| "ABIVAX Société Anonyme": 51099, | |
| "ABL Bio Inc.": 51263, | |
| "ABVC BioPharma, Inc.": 51244, | |
| "AC Immune SA": 50679, | |
| "ACADIA Pharmaceuticals Inc.": 50471, | |
| "ACRO Biomedical Co., Ltd.": 51262, | |
| "ADC Therapeutics SA": 51002, | |
| "ADMA Biologics, Inc.": 50824, | |
| "AEON Biopharma, Inc.": 51073, | |
| "AFC Agro Biotech Limited": 51074, | |
| "AGC Biologics S.p.A.": 50675, | |
| "AIM ImmunoTech Inc.": 50403, | |
| "ALTEOGEN Inc.": 50978, | |
| "ALX Oncology Holdings Inc.": 51185, | |
| "ARCA biopharma, Inc.": 50712, | |
| "ARS Pharmaceuticals, Inc.": 51430, | |
| "ASLAN Pharmaceuticals Limited": 51321, | |
| "AVEO Pharmaceuticals, Inc.": 50529, | |
| "AVITA Medical, Inc.": 50563, | |
| "AVROBIO, Inc.": 51245, | |
| "AXIM Biotechnologies, Inc.": 50948, | |
| "Aadi Bioscience, Inc.": 51332, | |
| "AbbVie Inc.": 50983, | |
| "Abbisko Cayman Limited": 51592, | |
| "Abcam plc": 50623, | |
| "Abeona Therapeutics Inc.": 50446, | |
| "Abera Bioscience AB": 51107, | |
| "Abliva AB (publ)": 50696, | |
| "Absci Corporation": 51120, | |
| "Acceleron Pharma Inc.": 50611, | |
| "Acelyrin, Inc.": 51558, | |
| "Acepodia, Inc.": 51487, | |
| "Aceragen, Inc.": 50379, | |
| "Achieve Life Sciences, Inc.": 51312, | |
| "Achiko AG": 51467, | |
| "Achilles Therapeutics plc": 51297, | |
| "Acorda Therapeutics, Inc.": 50359, | |
| "AcouSort AB (publ)": 51014, | |
| "Acrivon Therapeutics, Inc.": 51508, | |
| "Acrobiosystems Co.,Ltd.": 51568, | |
| "Acticor Biotech SAS": 51164, | |
| "Actinium Pharmaceuticals, Inc.": 50594, | |
| "Actinogen Medical Limited": 50763, | |
| "Active Biotech AB (publ)": 50490, | |
| "Acumen Pharmaceuticals, Inc.": 50605, | |
| "Acurx Pharmaceuticals, Inc.": 51391, | |
| "AdAlta Limited": 50852, | |
| "Adagene Inc.": 50943, | |
| "Adamas Pharmaceuticals, Inc.": 50820, | |
| "Adaptimmune Therapeutics plc": 50923, | |
| "Addex Therapeutics Ltd": 50535, | |
| "Adhera Therapeutics, Inc.": 51156, | |
| "Adicet Bio, Inc.": 51205, | |
| "Adimmune Corporation": 50744, | |
| "Aditxt, Inc.": 51380, | |
| "Adocia SA": 50788, | |
| "Advanced Proteome Therapeutics Corporation": 50738, | |
| "Advaxis, Inc.": 50595, | |
| "Adverum Biotechnologies, Inc.": 51016, | |
| "AegirBio AB (publ)": 51511, | |
| "Aeglea BioTherapeutics, Inc.": 51090, | |
| "Aerovate Therapeutics, Inc.": 51504, | |
| "Aeterna Zentaris Inc.": 50459, | |
| "Affimed N.V.": 50486, | |
| "AgeX Therapeutics, Inc.": 51342, | |
| "Agenus Inc.": 50457, | |
| "Agios Pharmaceuticals, Inc.": 50807, | |
| "Aileron Therapeutics, Inc.": 50674, | |
| "Aimmune Therapeutics, Inc.": 51062, | |
| "Ainos, Inc.": 50448, | |
| "Akari Therapeutics, Plc": 51197, | |
| "Akebia Therapeutics, Inc.": 50766, | |
| "Akero Therapeutics, Inc.": 51411, | |
| "Akeso, Inc.": 51513, | |
| "Akouos, Inc.": 51363, | |
| "Alaunos Therapeutics, Inc.": 50645, | |
| "Albert Labs International Corp.": 51563, | |
| "Albireo Pharma, Inc.": 50791, | |
| "Aldeyra Therapeutics, Inc.": 50808, | |
| "Alector, Inc.": 51078, | |
| "Alexion Pharmaceuticals, Inc.": 50443, | |
| "Aligos Therapeutics, Inc.": 51423, | |
| "Alkermes plc": 50361, | |
| "Allakos Inc.": 51036, | |
| "Allarity Therapeutics, Inc.": 51040, | |
| "Allena Pharmaceuticals, Inc.": 50985, | |
| "Allied Biotech Corporation": 50831, | |
| "Alligator Bioscience AB (publ)": 50547, | |
| "AlloVir, Inc.": 51287, | |
| "Allogene Therapeutics, Inc.": 51390, | |
| "Alnylam Pharmaceuticals, Inc.": 50537, | |
| "Alpha Cognition Inc.": 51210, | |
| "Alphamab Oncology": 51437, | |
| "Alpine Immune Sciences, Inc.": 51168, | |
| "Alterity Therapeutics Limited": 50531, | |
| "Altimmune, Inc.": 50570, | |
| "Alvotech": 51550, | |
| "Alzamend Neuro, Inc.": 51279, | |
| "Alzinova AB (publ)": 51003, | |
| "Amarin Corporation plc": 50456, | |
| "Ambrx Biopharma Inc.": 51583, | |
| "America Great Health": 51083, | |
| "American CryoStem Corporation": 50965, | |
| "American Films, Inc.": 50545, | |
| "Amgen Inc.": 50362, | |
| "Amicus Therapeutics, Inc.": 50582, | |
| "Amniotics AB (publ)": 51480, | |
| "Amoy Diagnostics Co., Ltd.": 51097, | |
| "Amplia Therapeutics Limited": 50705, | |
| "AnGes, Inc.": 50597, | |
| "AnaptysBio, Inc.": 50724, | |
| "Anavex Life Sciences Corp.": 50656, | |
| "Angiolab, Inc.": 50927, | |
| "Anhui Anke Biotechnology (Group) Co., Ltd.": 50869, | |
| "Anika Therapeutics, Inc.": 50439, | |
| "Anixa Biosciences, Inc.": 50431, | |
| "Annexon, Inc.": 51153, | |
| "Annovis Bio, Inc.": 51475, | |
| "Anti-Microbial Savior BioteQ Co., Ltd": 51597, | |
| "Apellis Pharmaceuticals, Inc.": 50898, | |
| "Apexigen, Inc.": 50917, | |
| "Apogee Therapeutics, Inc.": 51613, | |
| "Apollomics, Inc.": 51286, | |
| "Aposense Ltd.": 50465, | |
| "Applied Genetic Technologies Corporation": 50584, | |
| "Applied Molecular Transport Inc.": 51178, | |
| "Applied Therapeutics, Inc.": 51395, | |
| "Aprea Therapeutics, Inc.": 51251, | |
| "AprilBio Co.,Ltd.": 51468, | |
| "Aptahem AB (publ)": 51152, | |
| "Aptamer Group plc": 51415, | |
| "Aptevo Therapeutics Inc.": 51257, | |
| "Aptinyx Inc.": 51265, | |
| "Aptorum Group Limited": 51093, | |
| "Aptose Biosciences Inc.": 50406, | |
| "Apures Co., Ltd.": 51490, | |
| "AquaBounty Technologies, Inc.": 50474, | |
| "Aravive, Inc.": 50845, | |
| "Arbutus Biopharma Corporation": 50750, | |
| "Arcellx, Inc.": 51206, | |
| "Arctic Bioscience AS": 51572, | |
| "ArcticZymes Technologies ASA": 50655, | |
| "Arcturus Therapeutics Holdings Inc.": 51048, | |
| "Arcus Biosciences, Inc.": 51243, | |
| "Arcutis Biotherapeutics, Inc.": 51378, | |
| "Ardelyx, Inc.": 50841, | |
| "Arecor Therapeutics plc": 50784, | |
| "Arena Pharmaceuticals, Inc.": 50363, | |
| "Aridis Pharmaceuticals, Inc.": 50752, | |
| "Armata Pharmaceuticals, Inc.": 50880, | |
| "Aroa Biosurgery Limited": 50847, | |
| "Arrowhead Pharmaceuticals, Inc.": 50425, | |
| "Arterra Bioscience S.p.A.": 51495, | |
| "Ascelia Pharma AB (publ)": 50616, | |
| "Ascendis Pharma A/S": 50787, | |
| "Ascentage Pharma Group International": 51474, | |
| "Ascletis Pharma Inc.": 51418, | |
| "Asia Green Biotechnology Corp.": 51404, | |
| "Assembly Biosciences, Inc.": 50884, | |
| "Astria Therapeutics, Inc.": 50892, | |
| "Atara Biotherapeutics, Inc.": 51075, | |
| "Athenex, Inc.": 50691, | |
| "Athersys, Inc.": 50364, | |
| "Atossa Therapeutics, Inc.": 50890, | |
| "Atreca, Inc.": 50981, | |
| "Aura Biosciences, Inc.": 50889, | |
| "Aurinia Pharmaceuticals Inc.": 50492, | |
| "Autolus Therapeutics plc": 51400, | |
| "Avacta Group Plc": 50686, | |
| "Avalo Therapeutics, Inc.": 50991, | |
| "Avid Bioservices, Inc.": 50424, | |
| "Avidity Biosciences, Inc.": 51101, | |
| "Awakn Life Sciences Corp.": 51526, | |
| "Axcella Health Inc.": 50952, | |
| "Ayala Pharmaceuticals, Inc.": 51369, | |
| "BBS-Bioactive Bone Substitutes Oyj": 51026, | |
| "BCAL Diagnostics Limited": 51270, | |
| "BELLUS Health Inc.": 50404, | |
| "BGI Genomics Co., Ltd.": 51228, | |
| "BIO-FD&C Co.,Ltd.": 51272, | |
| "BIOTON S.A.": 50676, | |
| "BLIRT S.A.": 50944, | |
| "BNC Korea Co., Ltd.": 51150, | |
| "BSF Enterprise Plc": 51451, | |
| "Basilea Pharmaceutica AG": 50516, | |
| "Bavarian Nordic A/S": 50590, | |
| "Beam Therapeutics Inc.": 51403, | |
| "BeiGene, Ltd.": 50932, | |
| "Beijing Kawin Technology Share-Holding Co., Ltd.": 50855, | |
| "Beijing Leadman Biochemistry Co.,Ltd.": 50914, | |
| "Beijing Luzhu Biotechnology Co., Ltd.": 51333, | |
| "Beijing SL Pharmaceutical Co., Ltd.": 50673, | |
| "Beijing Science Sun Pharmaceutical Co., Ltd.": 51118, | |
| "Beijing Tiantan Biological Products Co., Ltd.": 50628, | |
| "Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.": 50768, | |
| "Bellerophon Therapeutics, Inc.": 51103, | |
| "Bellicum Pharmaceuticals, Inc.": 50730, | |
| "Benitec Biopharma Inc.": 50566, | |
| "BerGenBio ASA": 50902, | |
| "Beroni Group Limited": 51306, | |
| "Berry Genomics Co.,Ltd": 51018, | |
| "BeyondSpring Inc.": 51302, | |
| "Bharat Immunologicals & Biologicals Corporation Limited": 50658, | |
| "BiVictriX Therapeutics Plc": 51314, | |
| "Bicycle Therapeutics plc": 50870, | |
| "Bio Preventive Medicine Corp.": 51268, | |
| "Bio-Path Holdings, Inc.": 50772, | |
| "Bio-Thera Solutions, Ltd.": 51438, | |
| "BioArctic AB (publ)": 50688, | |
| "BioAtla, Inc.": 50896, | |
| "BioCardia, Inc.": 50626, | |
| "BioCryst Pharmaceuticals, Inc.": 50365, | |
| "BioGaia AB (publ)": 50557, | |
| "BioGend Therapeutics Co., Ltd.": 51379, | |
| "BioInvent International AB (publ)": 50418, | |
| "BioLineRx Ltd.": 50571, | |
| "BioMarin Pharmaceutical Inc.": 50366, | |
| "BioNTech SE": 50825, | |
| "BioNote, Inc.": 50886, | |
| "BioPorto A/S": 50642, | |
| "BioRestorative Therapies, Inc.": 50840, | |
| "BioVie Inc.": 51063, | |
| "BioXcel Therapeutics, Inc.": 51364, | |
| "Bioasis Technologies Inc.": 50780, | |
| "Bioceltix S.A.": 51453, | |
| "Biocept, Inc.": 50508, | |
| "Biocon Limited": 50606, | |
| "Biocure Technology Inc.": 50871, | |
| "Biocytogen Pharmaceuticals (Beijing) Co., Ltd.": 51612, | |
| "Biodexa Pharmaceuticals Plc": 51148, | |
| "Bioerg Spólka Akcyjna": 50950, | |
| "Biogen Inc.": 50380, | |
| "Biohaven Pharmaceutical Holding Company Ltd.": 51089, | |
| "Bioleaders Corporation": 50867, | |
| "BiomX Inc.": 51334, | |
| "Biomea Fusion, Inc.": 51556, | |
| "Biomm S.A.": 50665, | |
| "Bioneer Corporation": 50634, | |
| "Bionomics Limited": 50551, | |
| "Biora Therapeutics, Inc.": 51095, | |
| "Bioray Biotech Co., Ltd": 51422, | |
| "Biosergen AB": 50725, | |
| "Biosino Bio-Technology and Science Incorporation": 50709, | |
| "Biotest Aktiengesellschaft": 50564, | |
| "Biotron Limited": 50587, | |
| "Bioventix PLC": 50689, | |
| "Biovica International AB (publ)": 51087, | |
| "Bioxytran, Inc.": 51425, | |
| "Black Diamond Therapeutics, Inc.": 51328, | |
| "Blau Farmacêutica S.A.": 50811, | |
| "Bloomage BioTechnology Corporation Limited": 50814, | |
| "Blueprint Medicines Corporation": 50958, | |
| "Bolt Biotherapeutics, Inc.": 51182, | |
| "Bone Biologics Corporation": 50883, | |
| "Bone Therapeutics SA": 50860, | |
| "Bonesupport Holding AB (publ)": 51331, | |
| "Bonus BioGroup Ltd.": 50972, | |
| "Brainstorm Cell Therapeutics Inc.": 50612, | |
| "BriaCell Therapeutics Corp.": 51114, | |
| "Bridge Biotherapeutics, Inc.": 51249, | |
| "BridgeBio Pharma, Inc.": 51307, | |
| "Bright Minds Biosciences Inc.": 51546, | |
| "BrightPath Biotherapeutics Co., Ltd.": 50827, | |
| "Brii Biosciences Limited": 51405, | |
| "Burning Rock Biotech Limited": 51204, | |
| "Burzynski Research Institute, Inc.": 50540, | |
| "C4 Therapeutics, Inc.": 51233, | |
| "CANbridge Pharmaceuticals Inc.": 51589, | |
| "CARsgen Therapeutics Holdings Limited": 51582, | |
| "CASI Pharmaceuticals, Inc.": 50445, | |
| "CEL-SCI Corporation": 50429, | |
| "CK Life Sciences Int'l., (Holdings) Inc.": 50586, | |
| "COMPASS Pathways plc": 51421, | |
| "CRISPR Therapeutics AG": 51115, | |
| "CSL Limited": 50489, | |
| "CStone Pharmaceuticals": 51455, | |
| "CTI BioPharma Corp.": 50368, | |
| "Cabaletta Bio, Inc.": 51436, | |
| "Calidi Biotherapeutics, Inc.": 51413, | |
| "Calithera Biosciences, Inc.": 50911, | |
| "Can-Fite BioPharma Ltd.": 50470, | |
| "CanBas Co., Ltd.": 50707, | |
| "Candel Therapeutics, Inc.": 50771, | |
| "Cantargia AB (publ)": 50946, | |
| "Capricor Therapeutics, Inc.": 50729, | |
| "Capstone Therapeutics Corp.": 50441, | |
| "Cardiff Oncology, Inc.": 50636, | |
| "CareDx, Inc": 50629, | |
| "Caribou Biosciences, Inc.": 51134, | |
| "Carisma Therapeutics, Inc.": 51337, | |
| "Carmell Therapeutics Corporation": 50887, | |
| "Catalyst Biosciences, Inc.": 50602, | |
| "Catalyst Pharmaceuticals, Inc.": 50572, | |
| "Celcuity Inc.": 51094, | |
| "Cell Biotech Co., Ltd.": 50509, | |
| "Cell Source, Inc.": 51086, | |
| "CellSeed Inc.": 50574, | |
| "Celldex Therapeutics, Inc.": 50625, | |
| "Cellectar Biosciences, Inc.": 50773, | |
| "Cellectis S.A.": 50505, | |
| "Celltrion, Inc.": 50528, | |
| "Cellular Biomedicine Group, Inc.": 51030, | |
| "Celularity Inc.": 51295, | |
| "Celyad Oncology SA": 50754, | |
| "Centessa Pharmaceuticals plc": 51570, | |
| "Century Therapeutics, Inc.": 51479, | |
| "Cereno Scientific AB (publ)": 51022, | |
| "Cerevel Therapeutics Holdings, Inc.": 51432, | |
| "Cha Vaccine Research Institute Co., Ltd.": 51310, | |
| "Changchun BCHT Biotechnology Co.": 50959, | |
| "Checkmate Pharmaceuticals, Inc.": 51180, | |
| "Checkpoint Therapeutics, Inc.": 51172, | |
| "ChemoCentryx, Inc.": 50497, | |
| "Chemomab Therapeutics Ltd.": 51239, | |
| "Chempartner Pharmatech Co., Ltd.": 50931, | |
| "Chengdu Kanghua Biological Products Co., Ltd.": 50804, | |
| "Chengdu Olymvax Biopharmaceuticals Inc.": 51284, | |
| "Chimeric Therapeutics Limited": 51542, | |
| "Chimerix, Inc.": 50550, | |
| "China Regenerative Medicine International Limited": 50589, | |
| "China Resources Boya Bio-pharmaceutical Group Co., Ltd.": 50995, | |
| "Chinook Therapeutics, Inc.": 51489, | |
| "Chongqing Zhifei Biological Products Co., Ltd.": 50857, | |
| "Cibus, Inc.": 50949, | |
| "Cidara Therapeutics, Inc.": 51124, | |
| "Cizzle Biotechnology Holdings Plc": 50722, | |
| "Clal Biotechnology Industries Ltd.": 50462, | |
| "Clene Inc.": 51269, | |
| "Clinuvel Pharmaceuticals Limited": 50580, | |
| "Clover Biopharmaceuticals, Ltd.": 51584, | |
| "Clovis Oncology, Inc.": 50843, | |
| "Codiak BioSciences, Inc.": 51208, | |
| "Coeptis Therapeutics Holdings, Inc.": 51441, | |
| "Cogent Biosciences, Inc.": 51528, | |
| "CohBar, Inc.": 50968, | |
| "Coherus BioSciences, Inc.": 51012, | |
| "CollPlant Biotechnologies Ltd.": 50708, | |
| "CombiGene AB (publ)": 51135, | |
| "Comera Life Sciences Holdings, Inc.": 51611, | |
| "Compass Therapeutics, Inc.": 51122, | |
| "Concert Pharmaceuticals, Inc.": 50721, | |
| "Connect Biopharma Holdings Limited": 51573, | |
| "ContraFect Corporation": 50920, | |
| "Corbus Pharmaceuticals Holdings, Inc.": 51091, | |
| "Corium, Inc.": 50704, | |
| "Corvus Pharmaceuticals, Inc.": 51151, | |
| "Cotinga Pharmaceuticals Inc.": 50715, | |
| "Covalon Technologies Ltd.": 50624, | |
| "Coya Therapeutics, Inc.": 51561, | |
| "Creative Medical Technology Holdings, Inc.": 51246, | |
| "Crinetics Pharmaceuticals, Inc.": 51155, | |
| "Cue Biopharma, Inc.": 51317, | |
| "Cullinan Oncology, Inc.": 51356, | |
| "Cuorips Inc.": 51417, | |
| "Curacle Co., Ltd.": 51461, | |
| "Curasight A/S": 51529, | |
| "Curative Biotechnology, Inc.": 50800, | |
| "CureVac N.V.": 50668, | |
| "Curis, Inc.": 50369, | |
| "Cyclacel Pharmaceuticals, Inc.": 50408, | |
| "Cyclerion Therapeutics, Inc.": 51398, | |
| "Cyclo Therapeutics, Inc.": 50541, | |
| "Cynata Therapeutics Limited": 50777, | |
| "Cyteir Therapeutics, Inc.": 51169, | |
| "CytoDyn Inc.": 50630, | |
| "Cytokinetics, Incorporated": 50370, | |
| "CytomX Therapeutics, Inc.": 50851, | |
| "Cyxone AB (publ)": 51254, | |
| "D. Western Therapeutics Institute, Inc.": 50828, | |
| "DBV Technologies S.A.": 50583, | |
| "DNA Link, Inc.": 50874, | |
| "Daan Gene Co., Ltd.": 50641, | |
| "Daesung Microbiological Labs. Co., Ltd.": 50622, | |
| "Day One Biopharmaceuticals, Inc.": 51571, | |
| "Decibel Therapeutics, Inc.": 51209, | |
| "Deciphera Pharmaceuticals, Inc.": 50599, | |
| "Defence Therapeutics Inc.": 51345, | |
| "Delta-Fly Pharma, Inc.": 50997, | |
| "Denali Therapeutics Inc.": 51184, | |
| "DermTech, Inc.": 50476, | |
| "Dermata Therapeutics, Inc.": 51166, | |
| "Design Therapeutics, Inc.": 51477, | |
| "Destiny Pharma plc": 50419, | |
| "Devyser Diagnostics AB (publ)": 51554, | |
| "Dextech Medical AB": 51034, | |
| "DiNonA Inc.": 50693, | |
| "DiaMedica Therapeutics Inc.": 50561, | |
| "Diagonal Bio AB (publ)": 51581, | |
| "Diamyd Medical AB (publ)": 50813, | |
| "Dicerna Pharmaceuticals, Inc.": 50783, | |
| "Diffusion Pharmaceuticals Inc.": 50607, | |
| "Dimerix Limited": 50692, | |
| "Disc Medicine, Inc.": 51497, | |
| "Diurnal Group plc": 50706, | |
| "Dizal (Jiangsu) Pharmaceutical Co., Ltd.": 51366, | |
| "Dominari Holdings Inc.": 50428, | |
| "Dragon Life Science Holdings Group, Inc.": 50604, | |
| "Dyadic International, Inc.": 50559, | |
| "Dynavax Technologies Corporation": 50460, | |
| "Dyne Therapeutics, Inc.": 51464, | |
| "EOM Pharmaceuticals Holdings, Inc.": 51609, | |
| "EQRx, Inc.": 51506, | |
| "ESSA Pharma Inc.": 51141, | |
| "EXACT Therapeutics AS": 51426, | |
| "Eagle Pharmaceuticals, Inc.": 50552, | |
| "Edesa Biotech, Inc.": 51207, | |
| "Editas Medicine, Inc.": 51082, | |
| "Egetis Therapeutics AB (publ)": 50747, | |
| "Eiger BioPharmaceuticals, Inc.": 50830, | |
| "Eledon Pharmaceuticals, Inc.": 50866, | |
| "Elevation Oncology, Inc.": 51534, | |
| "Elicera Therapeutics AB (publ)": 51559, | |
| "Elicio Therapeutics, Inc.": 51020, | |
| "Eliem Therapeutics, Inc.": 51457, | |
| "Emergent BioSolutions Inc.": 50657, | |
| "Emergent Health Corp": 50781, | |
| "Enanta Pharmaceuticals, Inc.": 50442, | |
| "Endonovo Therapeutics, Inc.": 51001, | |
| "Energenesis Biomedical CO.,LTD.": 51350, | |
| "Enimmune corporation": 51224, | |
| "Enlivex Therapeutics Ltd.": 50878, | |
| "Ensol Biosciences Inc.": 50954, | |
| "Ensysce Biosciences, Inc.": 50826, | |
| "Entasis Therapeutics Holdings Inc.": 51393, | |
| "Entera Bio Ltd.": 50901, | |
| "Entheon Biomedical Corp.": 51522, | |
| "Entrada Therapeutics, Inc.": 51445, | |
| "Enzon Pharmaceuticals, Inc.": 50435, | |
| "Epigenomics AG": 50416, | |
| "Epizyme, Inc.": 50838, | |
| "Equillium, Inc.": 51420, | |
| "Erasca, Inc.": 51444, | |
| "Essex Bio-Technology Limited": 50598, | |
| "EuBiologics Co., Ltd.": 51060, | |
| "Eupraxia Pharmaceuticals Inc.": 51037, | |
| "Eurobio Scientific Société anonyme": 50412, | |
| "Eurocine Vaccines AB (publ)": 50514, | |
| "European Institute of Science AB (publ)": 50484, | |
| "Eutilex.Co.,Ltd": 51216, | |
| "Evaxion Biotech A/S": 51223, | |
| "Evelo Biosciences, Inc.": 51258, | |
| "Ever Supreme Bio Technology Co., Ltd": 51384, | |
| "Everest Medicines Limited": 51367, | |
| "Evgen Pharma plc": 50875, | |
| "Evogene Ltd.": 50549, | |
| "Evolutionary Genomics, Inc.": 51121, | |
| "Exact Sciences Corporation": 50373, | |
| "Exagen Inc.": 50603, | |
| "Exelixis, Inc.": 50374, | |
| "Exicure, Inc.": 50876, | |
| "Exopharm Limited": 51433, | |
| "ExpreS2ion Biotech Holding AB (publ)": 50924, | |
| "Exscientia plc": 51296, | |
| "F-star Therapeutics, Inc.": 51514, | |
| "Faron Pharmaceuticals Oy": 50765, | |
| "Fate Therapeutics, Inc.": 50782, | |
| "Fennec Pharmaceuticals Inc.": 50518, | |
| "FibroGen, Inc.": 50375, | |
| "Finch Therapeutics Group, Inc.": 51229, | |
| "First Wave BioPharma, Inc.": 51112, | |
| "Flexion Therapeutics, Inc.": 50853, | |
| "FluoGuide A/S": 51459, | |
| "Foghorn Therapeutics Inc.": 51354, | |
| "Forma Therapeutics Holdings, Inc.": 50999, | |
| "Formycon AG": 50879, | |
| "Forte Biosciences, Inc.": 51443, | |
| "Fortress Biotech, Inc.": 50861, | |
| "Forward Pharma A/S": 50728, | |
| "Foundation Medicine, Inc.": 50893, | |
| "Freeline Therapeutics Holdings plc": 51230, | |
| "Frequency Therapeutics, Inc.": 51313, | |
| "Fresh Tracks Therapeutics, Inc.": 50915, | |
| "Frontier Biotechnologies Inc.": 50976, | |
| "FunPep Company Limited": 51222, | |
| "Fusion Pharmaceuticals Inc.": 51323, | |
| "G1 Therapeutics, Inc.": 50979, | |
| "GC Biopharma Corp.": 50553, | |
| "GENINUS Inc.": 51473, | |
| "GI Innovation, Inc.": 51525, | |
| "GNI Group Ltd.": 50713, | |
| "GT Biopharma, Inc.": 50434, | |
| "Gain Therapeutics, Inc.": 51385, | |
| "Galapagos NV": 50524, | |
| "Galectin Therapeutics Inc.": 50500, | |
| "Galecto, Inc.": 50994, | |
| "Galera Therapeutics, Inc.": 51035, | |
| "Galmed Pharmaceuticals Ltd.": 50929, | |
| "Gamida Cell Ltd.": 50464, | |
| "Gan & Lee Pharmaceuticals.": 50897, | |
| "GeNeuro SA": 50815, | |
| "Gelesis Holdings, Inc.": 50751, | |
| "Gemina Laboratories Ltd.": 51578, | |
| "Gemini Therapeutics, Inc.": 51261, | |
| "GenMont Biotech Incorporation": 50659, | |
| "GenSight Biologics S.A.": 51049, | |
| "Gene Biotherapeutics, Inc.": 50697, | |
| "GeneOne Life Science, Inc.": 50621, | |
| "GeneTether Therapeutics Inc.": 51604, | |
| "GeneThera, Inc.": 50527, | |
| "Genelux Corporation": 50639, | |
| "Genenta Science S.p.A.": 51163, | |
| "General Biologicals Corporation": 50667, | |
| "Generation Bio Co.": 51375, | |
| "Generex Biotechnology Corporation": 50455, | |
| "Genesis IBRC India Limited": 50669, | |
| "Genetic Analysis AS": 50980, | |
| "Genetics Generation Advancement Corp.": 50969, | |
| "Genetron Holdings Limited": 51501, | |
| "Genexine, Inc.": 50601, | |
| "Genflow Biosciences plc": 51610, | |
| "Genmab A/S": 50469, | |
| "Genocea Biosciences, Inc.": 50740, | |
| "Genomed Spólka Akcyjna": 50793, | |
| "Genomics BioSci & Tech. Co.,Ltd.": 51071, | |
| "Genomtec S.A.": 51540, | |
| "Genor Biopharma Holdings Limited": 51478, | |
| "Genprex, Inc.": 51039, | |
| "Genus plc": 50499, | |
| "GeoVax Labs, Inc.": 50647, | |
| "Geron Corporation": 50426, | |
| "Getein Biotech, Inc": 51077, | |
| "Gilead Sciences, Inc.": 50378, | |
| "Global Blood Therapeutics, Inc.": 51017, | |
| "GlobeStar Therapeutics Corporation": 51276, | |
| "GlycoMimetics, Inc.": 50577, | |
| "GlycoNex Incorporation": 50984, | |
| "Golden Biotechnology Corporation": 50833, | |
| "Gongwin Biopharm Holdings Co., Ltd.": 51309, | |
| "Gossamer Bio, Inc.": 51376, | |
| "Grace Breeding Ltd": 51607, | |
| "Gracell Biotechnologies Inc.": 51458, | |
| "Graphite Bio, Inc.": 51541, | |
| "Green Cross Cell Corporation": 50576, | |
| "Green Cross Holdings Corporation": 50653, | |
| "Greenwich LifeSciences, Inc.": 51509, | |
| "Grifols, S.A.": 50478, | |
| "Gritstone bio, Inc.": 51211, | |
| "Guangdong Hybribio Biotech Co.,Ltd.": 51195, | |
| "Guangdong VTR Bio-Tech Co., Ltd.": 50921, | |
| "Guanhao Biotech Co.,Ltd.": 50906, | |
| "Guard Therapeutics International AB (publ)": 51013, | |
| "HAVN Life Sciences Inc.": 51524, | |
| "HBM Holdings Limited": 51552, | |
| "HCW Biologics Inc.": 51482, | |
| "HOB Biotech Group Corp.,Ltd": 50907, | |
| "HOOKIPA Pharma Inc.": 51409, | |
| "HST Global, Inc.": 50801, | |
| "Halberd Corporation": 50836, | |
| "Halozyme Therapeutics, Inc.": 50596, | |
| "Hangzhou Biotest Biotech Co.,Ltd.": 51491, | |
| "HansBiomed Corporation": 50864, | |
| "Hansa Biopharma AB (publ)": 50648, | |
| "Harpoon Therapeutics, Inc.": 51308, | |
| "Healios K.K.": 51047, | |
| "Heidelberg Pharma AG": 50411, | |
| "Helix BioPharma Corp.": 50488, | |
| "Helixmith Co., Ltd": 50681, | |
| "Hemogenyx Pharmaceuticals Plc": 51347, | |
| "Hemostemix Inc.": 51053, | |
| "Heron Therapeutics, Inc.": 50360, | |
| "Hester Biosciences Limited": 50663, | |
| "Hexima Limited": 50759, | |
| "HilleVax, Inc.": 51596, | |
| "Hillstream BioPharma, Inc.": 51341, | |
| "Hindustan Bio Sciences Limited": 50660, | |
| "Histogen Inc.": 50799, | |
| "Hofseth BioCare ASA": 50974, | |
| "Holy Stone Healthcare Co., Ltd.": 51080, | |
| "Homology Medicines, Inc.": 51232, | |
| "Horizon Therapeutics Public Limited Company": 50891, | |
| "Hualan Biological Bacterin Inc.": 51144, | |
| "Hualan Biological Engineering Inc.": 50651, | |
| "Hubei Goto Biopharm Co.,Ltd.": 51238, | |
| "Hugel, Inc.": 51042, | |
| "Humacyte, Inc.": 50904, | |
| "Humanigen, Inc.": 50579, | |
| "I-Mab": 51499, | |
| "IBEX Technologies Inc.": 50405, | |
| "IDEAYA Biosciences, Inc.": 51250, | |
| "IGM Biosciences, Inc.": 51213, | |
| "IMV Inc.": 50593, | |
| "IN8bio, Inc.": 51387, | |
| "INmune Bio, Inc.": 51344, | |
| "IO Biotech, Inc.": 51602, | |
| "ISR Immune System Regulation Holding AB (publ)": 51318, | |
| "IVERIC bio, Inc.": 50762, | |
| "Icosavax, Inc.": 51472, | |
| "Idogen AB (publ)": 51027, | |
| "Idorsia Ltd": 51319, | |
| "Imago BioSciences, Inc.": 51142, | |
| "Imeik Technology Development Co.,Ltd.": 51343, | |
| "Immatics N.V.": 50609, | |
| "Immix Biopharma, Inc.": 51315, | |
| "ImmuCell Corporation": 50381, | |
| "Immune Therapeutics, Inc.": 51015, | |
| "Immuneering Corporation": 51201, | |
| "Immunic, Inc.": 51290, | |
| "ImmunityBio, Inc.": 51187, | |
| "ImmunoCellular Therapeutics, Ltd.": 50718, | |
| "ImmunoGen, Inc.": 50382, | |
| "Immunocore Holdings plc": 50963, | |
| "Immunome, Inc.": 50908, | |
| "Immunotech Biopharm Ltd": 51399, | |
| "Immunovant, Inc.": 51439, | |
| "Immuron Limited": 50588, | |
| "Immutep Limited": 50581, | |
| "Imugene Limited": 50638, | |
| "Imunon, Inc.": 50430, | |
| "Incyte Corporation": 50440, | |
| "Indaptus Therapeutics, Inc.": 51147, | |
| "Infinity Pharmaceuticals, Inc.": 50504, | |
| "InflaRx N.V.": 50796, | |
| "Inhibikase Therapeutics, Inc.": 50925, | |
| "Inhibitor Therapeutics, Inc.": 50449, | |
| "Inhibrx, Inc.": 51402, | |
| "Initiator Pharma A/S": 51266, | |
| "Innate Pharma S.A.": 50461, | |
| "InnoCare Pharma Limited": 51500, | |
| "Innovation Pharmaceuticals Inc.": 50786, | |
| "Innovent Biologics, Inc.": 50977, | |
| "Inovio Pharmaceuticals, Inc.": 50377, | |
| "Inozyme Pharma, Inc.": 51408, | |
| "Insmed Incorporated": 50383, | |
| "Instil Bio, Inc.": 51493, | |
| "IntegraGen SA": 50519, | |
| "Intellia Therapeutics, Inc.": 51146, | |
| "Intensity Therapeutics, Inc.": 51038, | |
| "Intercept Pharmaceuticals, Inc.": 50640, | |
| "International Stem Cell Corporation": 50736, | |
| "Intervacc AB (publ)": 50940, | |
| "InventisBio Co., Ltd.": 51336, | |
| "Inventiva S.A.": 51137, | |
| "Ionis Pharmaceuticals, Inc.": 50384, | |
| "Iovance Biotherapeutics, Inc.": 50789, | |
| "Iris BioTechnologies, Inc.": 50746, | |
| "Ironwood Pharmaceuticals, Inc.": 50388, | |
| "Isofol Medical AB (publ)": 50809, | |
| "JW (Cayman) Therapeutics Co. Ltd": 51532, | |
| "Jacobio Pharmaceuticals Group Co., Ltd.": 51406, | |
| "Janux Therapeutics, Inc.": 51530, | |
| "Japan Tissue Engineering Co., Ltd.": 50732, | |
| "Jasper Therapeutics, Inc.": 51502, | |
| "Jiangsu Aidea Pharmaceutical Co., Ltd.": 51329, | |
| "Jiangsu CoWin Biotech Co., Ltd.": 51599, | |
| "Jiangsu Recbio Technology Co., Ltd.": 51555, | |
| "Jiangsu Sihuan Bioengineering Co., Ltd": 50614, | |
| "Jinyu Bio-technology Co., Ltd.": 50652, | |
| "Jounce Therapeutics, Inc.": 51044, | |
| "Kadimastem Ltd": 51033, | |
| "Kadmon Holdings, Inc.": 50930, | |
| "Kainos Medicine, Inc.": 50936, | |
| "KalVista Pharmaceuticals, Inc.": 50971, | |
| "Kamada Ltd.": 50610, | |
| "Kancera AB (publ)": 50937, | |
| "Kane Biotech Inc.": 50567, | |
| "Kangstem Biotech Co., Ltd.": 51117, | |
| "Karuna Therapeutics, Inc.": 50967, | |
| "Karyopharm Therapeutics Inc.": 50934, | |
| "Kazia Therapeutics Limited": 50454, | |
| "Keros Therapeutics, Inc.": 51259, | |
| "Keymed Biosciences Inc.": 51585, | |
| "Kezar Life Sciences, Inc.": 51192, | |
| "Kiadis Pharma N.V.": 50494, | |
| "Kidswell Bio Corporation": 50865, | |
| "Kim Forest Enterprise Co., Ltd.": 51338, | |
| "Kindred Biosciences, Inc.": 51032, | |
| "Kineta, Inc.": 50877, | |
| "Kiniksa Pharmaceuticals, Ltd.": 51392, | |
| "Kinnate Biopharma Inc.": 51389, | |
| "Kintara Therapeutics, Inc.": 50926, | |
| "Kintor Pharmaceutical Limited": 50910, | |
| "Kiromic BioPharma, Inc.": 51515, | |
| "Kite Pharma, Inc.": 50947, | |
| "KoBioLabs, Inc": 51447, | |
| "Kodiak Sciences Inc.": 51235, | |
| "Kolon TissueGene, Inc.": 50678, | |
| "Kringle Pharma, Inc.": 50672, | |
| "Kronos Bio, Inc.": 51396, | |
| "Krystal Biotech, Inc.": 51348, | |
| "Kura Oncology, Inc.": 51162, | |
| "Kuros Biosciences AG": 50562, | |
| "Kymera Therapeutics, Inc.": 51362, | |
| "L&C Bio Co., Ltd": 51299, | |
| "LAVA Therapeutics N.V.": 51371, | |
| "LIDDS AB (publ)": 50743, | |
| "La Jolla Pharmaceutical Company": 50385, | |
| "LabGenomics Co., Ltd.": 50733, | |
| "LadRx Corporation": 50433, | |
| "Landfar Bio-medicine Co., Ltd": 50575, | |
| "Lantern Pharma Inc.": 51132, | |
| "Larimar Therapeutics, Inc.": 51414, | |
| "Leap Therapeutics, Inc.": 50942, | |
| "Legend Biotech Corporation": 51383, | |
| "Lepu Biopharma Co., Ltd.": 51605, | |
| "Lexicon Pharmaceuticals, Inc.": 50386, | |
| "Lexston Life Sciences Corp.": 51533, | |
| "LianBio": 51536, | |
| "Liaoning Chengda Biotechnology Co.,Ltd.": 50844, | |
| "Lifecome Biochemistry Co.,Ltd.": 50895, | |
| "Liminal BioSciences Inc.": 50491, | |
| "Lin BioScience, Inc.": 51388, | |
| "Lineage Cell Therapeutics, Inc.": 50367, | |
| "Lipella Pharmaceuticals Inc.": 50760, | |
| "Lipigon Pharmaceuticals AB (publ)": 51029, | |
| "Lipum AB (publ)": 51253, | |
| "Lixte Biotechnology Holdings, Inc.": 50727, | |
| "LogicBio Therapeutics, Inc.": 51236, | |
| "Longeveron Inc.": 51305, | |
| "Loxo Oncology, Inc.": 51064, | |
| "Lumos Pharma, Inc.": 51096, | |
| "LungLife AI, Inc.": 50850, | |
| "Lyell Immunopharma, Inc.": 51435, | |
| "Lysogene S.A.": 50987, | |
| "Lytix Biopharma AS": 50734, | |
| "MAIA Biotechnology, Inc.": 51485, | |
| "MDxHealth SA": 50569, | |
| "MEI Pharma, Inc.": 50530, | |
| "MaaT Pharma SA": 51160, | |
| "Mabion S.A.": 50916, | |
| "Mabpharm Limited": 51470, | |
| "Mabwell (Shanghai) Bioscience Co., Ltd.": 51520, | |
| "MacroGenics, Inc.": 50467, | |
| "Madrigal Pharmaceuticals, Inc.": 50989, | |
| "Magenta Therapeutics, Inc.": 51303, | |
| "Mainz Biomed N.V.": 51595, | |
| "Manhattan Scientifics, Inc.": 50479, | |
| "MannKind Corporation": 50619, | |
| "Marizyme, Inc.": 50775, | |
| "Marker Therapeutics, Inc.": 50526, | |
| "Marvel Biosciences Corp.": 51539, | |
| "Matinas BioPharma Holdings, Inc.": 51066, | |
| "Matricelf Ltd": 51579, | |
| "MedPacto, Inc.": 51227, | |
| "Medesis Pharma S.A.": 50919, | |
| "Medicenna Therapeutics Corp.": 51070, | |
| "MediciNova, Inc.": 50618, | |
| "Medicure Inc.": 50544, | |
| "Medigen Biotechnology Corp.": 50600, | |
| "Medigen Vaccine Biologics Corporation": 51189, | |
| "Medigene AG": 50387, | |
| "Medivir AB (publ)": 50532, | |
| "Medlab Clinical Limited": 51176, | |
| "Medy-Tox Inc.": 50741, | |
| "MegaPro Biomedical Co., Ltd": 51407, | |
| "MeiraGTx Holdings plc": 51293, | |
| "Mereo BioPharma Group plc": 51200, | |
| "Merrimack Pharmaceuticals, Inc.": 50523, | |
| "Mersana Therapeutics, Inc.": 50522, | |
| "Merus N.V.": 50703, | |
| "Mesoblast Limited": 50661, | |
| "Metacrine, Inc.": 51177, | |
| "MiMedx Group, Inc.": 50761, | |
| "MiNK Therapeutics, Inc.": 51593, | |
| "Microbix Biosystems Inc.": 50389, | |
| "Millendo Therapeutics, Inc.": 51006, | |
| "Mineralys Therapeutics, Inc.": 51576, | |
| "Minerva Neurosciences, Inc.": 51108, | |
| "Mirati Therapeutics, Inc.": 50407, | |
| "Mirum Pharmaceuticals, Inc.": 51434, | |
| "Modalis Therapeutics Corporation": 51373, | |
| "Moderna, Inc.": 50951, | |
| "Modus Therapeutics Holding AB (publ)": 51577, | |
| "Molecular Partners AG": 50742, | |
| "Molecular Templates, Inc.": 50720, | |
| "Moleculin Biotech, Inc.": 51226, | |
| "Monopar Therapeutics Inc.": 51193, | |
| "Monte Rosa Therapeutics, Inc.": 51544, | |
| "MoonLake Immunotherapeutics": 51580, | |
| "Morphic Holding, Inc.": 51274, | |
| "MorphoSys AG": 50413, | |
| "Mustang Bio, Inc.": 51247, | |
| "Mycenax Biotech Inc.": 50821, | |
| "Mymetics Corporation": 50513, | |
| "Myovant Sciences Ltd.": 51291, | |
| "Myriad Genetics, Inc.": 50390, | |
| "NFL Biosciences SA": 51531, | |
| "NKGen Biotech, Inc.": 51446, | |
| "NanoLogix, Inc.": 50496, | |
| "NanoViricides, Inc.": 50683, | |
| "Nanobiotix S.A.": 50670, | |
| "Nanollose Limited": 51349, | |
| "Nanologica AB (publ)": 50973, | |
| "Nascent Biotech, Inc.": 51130, | |
| "Natera, Inc.": 50717, | |
| "Navidea Biopharmaceuticals, Inc.": 50438, | |
| "NeoImmuneTech, Inc.": 51157, | |
| "Neoleukin Therapeutics, Inc.": 50756, | |
| "Neovacs S.A.": 50578, | |
| "NeuBase Therapeutics, Inc.": 51448, | |
| "Neumora Therapeutics, Inc.": 51600, | |
| "NeuroBo Pharmaceuticals, Inc.": 51484, | |
| "NeuroScientific Biopharmaceuticals Limited": 51357, | |
| "NeuroSense Therapeutics Ltd.": 51381, | |
| "Neurocrine Biosciences, Inc.": 50391, | |
| "NexImmune, Inc.": 50990, | |
| "NextCell Pharma AB": 51179, | |
| "NextCure, Inc.": 51231, | |
| "Nextage Therapeutics Ltd": 51486, | |
| "Nicox S.A.": 50410, | |
| "Nkarta, Inc.": 51365, | |
| "Noile-Immune Biotech Inc.": 51351, | |
| "Nordic Nanovector ASA": 50939, | |
| "Northwest Biotherapeutics, Inc.": 50512, | |
| "NovAccess Global Inc.": 50546, | |
| "Nova Mentis Life Science Corp.": 50719, | |
| "Novacyt S.A.": 50817, | |
| "Novartis Gene Therapies, Inc.": 51104, | |
| "Novavax, Inc.": 50444, | |
| "Novelion Therapeutics Inc.": 50437, | |
| "Noxopharm Limited": 51275, | |
| "NuCana plc": 50823, | |
| "Nurix Therapeutics, Inc.": 51011, | |
| "Nutra Pharma Corp.": 50520, | |
| "Nuvalent, Inc.": 51567, | |
| "Nuvectis Pharma, Inc.": 51594, | |
| "Nykode Therapeutics AS": 50858, | |
| "Nymox Pharmaceutical Corporation": 50452, | |
| "OBI Pharma, Inc.": 50755, | |
| "OKYO Pharma Limited": 50805, | |
| "ORIC Pharmaceuticals, Inc.": 51188, | |
| "OSE Immunotherapeutics SA": 51031, | |
| "ObsEva SA": 51068, | |
| "Ocugen, Inc.": 51190, | |
| "Olema Pharmaceuticals, Inc.": 51359, | |
| "Omega Therapeutics, Inc.": 51463, | |
| "Oncimmune Holdings plc": 50798, | |
| "OncoCyte Corporation": 50872, | |
| "OncoSec Medical Incorporated": 50812, | |
| "OncoTherapy Science, Inc.": 50615, | |
| "Oncodesign Société Anonyme": 50472, | |
| "Oncolys BioPharma Inc.": 50758, | |
| "Oncolytics Biotech Inc.": 50511, | |
| "Oncopeptides AB (publ)": 50654, | |
| "Oncorus, Inc.": 51255, | |
| "Oncotelic Therapeutics, Inc.": 51242, | |
| "Oncternal Therapeutics, Inc.": 51273, | |
| "OpGen, Inc.": 50506, | |
| "Opthea Limited": 50533, | |
| "OptiBiotix Health Plc": 50957, | |
| "Oragenics, Inc.": 50483, | |
| "Orchard Therapeutics plc": 51264, | |
| "Organicell Regenerative Medicine, Inc.": 51023, | |
| "Organogenesis Holdings Inc.": 50436, | |
| "Organovo Holdings, Inc.": 50900, | |
| "Orgenesis Inc.": 50839, | |
| "Orphazyme A/S": 50885, | |
| "Orthocell Limited": 50837, | |
| "Oryzon Genomics S.A.": 50538, | |
| "Outlook Therapeutics, Inc.": 50992, | |
| "Ovid Therapeutics Inc.": 51174, | |
| "Oxford Biomedica plc": 50468, | |
| "Oxurion NV": 50487, | |
| "Oyster Point Pharma, Inc.": 51360, | |
| "PCI Biotech Holding ASA": 50803, | |
| "PDS Biotechnology Corporation": 50835, | |
| "PMV Pharmaceuticals, Inc.": 51106, | |
| "POINT Biopharma Global Inc.": 51512, | |
| "PTC Therapeutics, Inc.": 50498, | |
| "PYC Therapeutics Limited": 50677, | |
| "Pacific Edge Limited": 50635, | |
| "Pacific Shuanglin Bio-pharmacy Co., LTD": 50573, | |
| "Paion AG": 50536, | |
| "Palatin Technologies, Inc.": 50392, | |
| "Panacea Biotec Limited": 50608, | |
| "Panbela Therapeutics, Inc.": 51000, | |
| "Paradigm Biopharmaceuticals Limited": 51145, | |
| "Pardes Biosciences, Inc.": 51566, | |
| "Pasithea Therapeutics Corp.": 51569, | |
| "Passage Bio, Inc.": 51456, | |
| "Patrys Limited": 50757, | |
| "PeopleBio, Inc.": 50731, | |
| "PepGen Inc.": 51591, | |
| "PeptiDream Inc.": 50863, | |
| "Perseus Proteomics Inc.": 50710, | |
| "PharmAbcine Inc.": 50868, | |
| "Pharma Foods International Co., Ltd.": 50694, | |
| "Pharma Mar, S.A.": 50421, | |
| "PharmaCyte Biotech, Inc.": 50554, | |
| "PharmaEngine, Inc.": 50701, | |
| "PharmaEssentia Corporation": 50849, | |
| "PharmaLundensis AB": 50899, | |
| "PharmaResearch Co., Ltd.": 51052, | |
| "Pharming Group N.V.": 50393, | |
| "Pharnext SA": 50785, | |
| "PhaseBio Pharmaceuticals, Inc.": 50555, | |
| "Pherecydes Pharma Société anonyme": 51084, | |
| "Philogen S.p.A.": 50711, | |
| "Phio Pharmaceuticals Corp.": 50975, | |
| "Pieris Pharmaceuticals, Inc.": 50521, | |
| "Plant Advanced Technologies SA": 50859, | |
| "Plus Therapeutics, Inc.": 50432, | |
| "Polaris Group": 51237, | |
| "Poltreg S.A.": 51452, | |
| "Polyphor AG": 50503, | |
| "Portage Biotech Inc.": 51046, | |
| "Poseida Therapeutics, Inc.": 51186, | |
| "Poxel S.A.": 50912, | |
| "Praxis Precision Medicines, Inc.": 51301, | |
| "Precigen, Inc.": 50680, | |
| "Precision BioSciences, Inc.": 50790, | |
| "Predictive Technology Group, Inc.": 50737, | |
| "Predilife S.A.": 51442, | |
| "Prelude Therapeutics Incorporated": 51280, | |
| "Prescient Therapeutics Limited": 50565, | |
| "Prestige BioPharma Limited": 51326, | |
| "Prevail Therapeutics Inc.": 51386, | |
| "Prime Medicine, Inc.": 51590, | |
| "ProKidney Corp.": 51450, | |
| "ProMIS Neurosciences, Inc.": 50646, | |
| "ProQR Therapeutics N.V.": 51028, | |
| "ProText Mobility, Inc.": 51311, | |
| "Probi AB (publ)": 50502, | |
| "Prometheus Biosciences, Inc.": 51358, | |
| "Promore Pharma AB (publ)": 51294, | |
| "Propanc Biopharma, Inc.": 50970, | |
| "Prostatype Genomics AB (publ)": 51517, | |
| "Protagenic Therapeutics, Inc.": 50964, | |
| "Protagonist Therapeutics, Inc.": 50956, | |
| "Protalix BioTherapeutics, Inc.": 50495, | |
| "Protara Therapeutics, Inc.": 51368, | |
| "Prothena Corporation plc": 51021, | |
| "ProtoKinetix, Incorporated": 50592, | |
| "Psomagen, Inc.": 51320, | |
| "PsyBio Therapeutics Corp.": 51521, | |
| "Psyence Group Inc.": 51535, | |
| "Puma Biotechnology, Inc.": 50953, | |
| "PureTech Health plc": 50617, | |
| "Pyxis Oncology, Inc.": 51483, | |
| "Q BioMed Inc.": 51092, | |
| "QSAM Biosciences, Inc.": 50894, | |
| "Qingdao Vland Biotech INC.": 51171, | |
| "Qrons Inc.": 51298, | |
| "Qualigen Therapeutics, Inc.": 50517, | |
| "QuantaMatrix Inc.": 51170, | |
| "Quantum Genomics Société Anonyme": 50682, | |
| "Quest PharmaTech Inc.": 50525, | |
| "QuiaPEG Pharmaceuticals Holding AB (publ)": 50475, | |
| "Quince Therapeutics, Inc.": 51123, | |
| "Quoin Pharmaceuticals, Ltd.": 51440, | |
| "Qurient Co., Ltd.": 50933, | |
| "RAPT Therapeutics, Inc.": 51139, | |
| "REGENXBIO Inc.": 50960, | |
| "RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.": 51119, | |
| "Race Oncology Limited": 51267, | |
| "Radiopharm Theranostics Limited": 51603, | |
| "Radius Health, Inc.": 50627, | |
| "Rakovina Therapeutics Inc.": 51523, | |
| "Rallybio Corporation": 51588, | |
| "Raphael Pharmaceutical Inc.": 51587, | |
| "Rasna Therapeutics, Inc.": 51285, | |
| "RayzeBio, Inc.": 51548, | |
| "ReNeuron Group plc": 50409, | |
| "Read-Gene S.A.": 50829, | |
| "Rebus Holdings, Inc.": 50816, | |
| "Recursion Pharmaceuticals, Inc.": 51110, | |
| "Regen BioPharma, Inc.": 51009, | |
| "RegeneRx Biopharmaceuticals, Inc.": 50427, | |
| "Regeneron Pharmaceuticals, Inc.": 50395, | |
| "Regeneus Ltd": 51067, | |
| "Regenicin, Inc.": 50776, | |
| "Regulus Therapeutics Inc.": 50767, | |
| "Relay Therapeutics, Inc.": 51288, | |
| "Relief Therapeutics Holding AG": 51143, | |
| "RemeGen Co., Ltd.": 51551, | |
| "Reneo Pharmaceuticals, Inc.": 51149, | |
| "RenovaCare, Inc.": 50543, | |
| "Renovacor, Inc.": 51488, | |
| "RenovoRx, Inc.": 51050, | |
| "Repare Therapeutics Inc.": 51340, | |
| "Replimune Group, Inc.": 51410, | |
| "ReproCELL Incorporated": 50764, | |
| "Respiratorius AB (publ)": 50716, | |
| "Resverlogix Corp.": 50539, | |
| "Reunion Neuroscience Inc.": 51510, | |
| "Revelation Biosciences, Inc.": 51557, | |
| "Revolution Medicines, Inc.": 51167, | |
| "Rezolute, Inc.": 50998, | |
| "RhoVac AB": 51234, | |
| "Rhythm Pharmaceuticals, Inc.": 51202, | |
| "Ribomic Inc.": 50810, | |
| "Rich Pharmaceuticals, Inc.": 50961, | |
| "Rigel Pharmaceuticals, Inc.": 50396, | |
| "Rocket Pharmaceuticals, Inc.": 51330, | |
| "Roivant Sciences Ltd.": 51161, | |
| "Roquefort Therapeutics plc": 51553, | |
| "Rubius Therapeutics, Inc.": 51220, | |
| "SAB Biotherapeutics, Inc.": 51128, | |
| "SELLAS Life Sciences Group, Inc.": 51113, | |
| "SK bioscience Co.,Ltd.": 51419, | |
| "SQZ Biotechnologies Company": 51111, | |
| "Sage Therapeutics, Inc.": 50982, | |
| "Sagimet Biosciences Inc.": 50753, | |
| "Salarius Pharmaceuticals, Inc.": 51252, | |
| "SanBio Company Limited": 51138, | |
| "Sana Biotechnology, Inc.": 51449, | |
| "Sangamo Therapeutics, Inc.": 50458, | |
| "Sangui Biotech International, Inc.": 50548, | |
| "Saniona AB (publ)": 51105, | |
| "Santhera Pharmaceuticals Holding AG": 50643, | |
| "Sarepta Therapeutics, Inc.": 50447, | |
| "Satellos Bioscience Inc.": 51505, | |
| "Savara Inc.": 50842, | |
| "Scancell Holdings plc": 50463, | |
| "Scandion Oncology A/S": 51372, | |
| "Scholar Rock Holding Corporation": 51377, | |
| "SciSparc Ltd.": 50690, | |
| "Scopus BioPharma Inc.": 51476, | |
| "Seagen Inc.": 50397, | |
| "Seegene, Inc.": 50620, | |
| "Selecta Biosciences, Inc.": 50832, | |
| "Senhwa Biosciences, Inc.": 51085, | |
| "Sensei Biotherapeutics, Inc.": 50477, | |
| "Sensorion SA": 51005, | |
| "Senti Biosciences, Inc.": 51355, | |
| "SenzaGen AB": 51154, | |
| "Seoulin Bioscience Co.,Ltd.": 50699, | |
| "Sera Prognostics, Inc.": 50941, | |
| "Seres Therapeutics, Inc.": 51025, | |
| "Sernova Corp.": 50473, | |
| "Sesen Bio, Inc.": 50882, | |
| "Shandong Kexing Bioproducts Co,.Ltd": 50903, | |
| "Shanghai Haohai Biological Technology Co., Ltd.": 50909, | |
| "Shanghai Henlius Biotech, Inc.": 51056, | |
| "Shanghai Junshi Biosciences Co., Ltd.": 51203, | |
| "Shanghai MicuRx Pharmaceutical Co., Ltd.": 51606, | |
| "Shanghai OPM Biosciences Co., Ltd.": 51361, | |
| "Shanghai RAAS Blood Products Co., Ltd.": 50769, | |
| "Shanghai Rightongene Biotechnology Co., Ltd.": 51527, | |
| "Shanghai Serum Bio-Technology Co., Ltd.": 51010, | |
| "Shaperon Inc.": 51401, | |
| "Shattuck Labs, Inc.": 51282, | |
| "Shenzhen Kangtai Biological Products Co., Ltd.": 50854, | |
| "Shenzhen Weiguang Biological Products Co., Ltd.": 50848, | |
| "Shuttle Pharmaceuticals Holdings, Inc.": 51225, | |
| "Sierra Oncology, Inc.": 50631, | |
| "Sigilon Therapeutics, Inc.": 51339, | |
| "Silence Therapeutics plc": 50423, | |
| "SillaJen, Inc.": 51058, | |
| "Silo Pharma, Inc.": 50955, | |
| "Silverback Therapeutics, Inc.": 51256, | |
| "Sino Biological,Inc.": 51045, | |
| "SinoMab BioScience Limited": 50888, | |
| "Sinocelltech Group Limited": 51416, | |
| "Sinovac Biotech Ltd.": 50585, | |
| "Sio Gene Therapies Inc.": 51183, | |
| "Sirnaomics Ltd.": 51608, | |
| "Sirona Biochem Corp.": 50745, | |
| "SkinBioTherapeutics Plc": 51292, | |
| "Skye Bioscience, Inc.": 51125, | |
| "Smart Agro - Limited": 51549, | |
| "Solasia Pharma K.K.": 50770, | |
| "Soleno Therapeutics, Inc.": 50534, | |
| "Solid Biosciences Inc.": 51215, | |
| "Soligenix, Inc.": 50372, | |
| "Sonnet BioTherapeutics Holdings, Inc.": 51304, | |
| "Sorrento Therapeutics, Inc.": 50846, | |
| "Spago Nanomedical AB (publ)": 50818, | |
| "Spark Therapeutics, Inc.": 51079, | |
| "Spectral Medical Inc.": 50398, | |
| "Spectrum Pharmaceuticals, Inc.": 50450, | |
| "Spero Therapeutics, Inc.": 51054, | |
| "Spexis AG": 51133, | |
| "SpringWorks Therapeutics, Inc.": 51465, | |
| "Sprint Bioscience AB (publ)": 50922, | |
| "Spruce Biosciences, Inc.": 51316, | |
| "StageZero Life Sciences Ltd.": 50542, | |
| "Statera Biopharma, Inc.": 51116, | |
| "Stealth BioTherapeutics Corp": 50822, | |
| "Stem Cells Spin S.A.": 50913, | |
| "StemRIM": 51481, | |
| "Stoke Therapeutics, Inc.": 51081, | |
| "Summit Therapeutics Inc.": 50644, | |
| "SunBio,Inc.": 50702, | |
| "Sunmax Biotechnology Co., Ltd.": 50834, | |
| "Sunshine Biopharma, Inc.": 50873, | |
| "Surface Oncology, Inc.": 51159, | |
| "Surrozen, Inc.": 51289, | |
| "Sutro Biopharma, Inc.": 50779, | |
| "Suzhou Zelgen Biopharmaceuticals Co., Ltd.": 51281, | |
| "Swedish Orphan Biovitrum AB (publ)": 50501, | |
| "SynAct Pharma AB": 51260, | |
| "Synairgen plc": 50662, | |
| "Synaptogenix, Inc.": 51129, | |
| "Syndax Pharmaceuticals, Inc.": 50714, | |
| "Synlogic, Inc.": 51127, | |
| "Syros Pharmaceuticals, Inc.": 51051, | |
| "T2 Biosystems, Inc.": 50735, | |
| "TC Biopharm (Holdings) Plc": 51598, | |
| "TCM Biotech International Corp.": 51008, | |
| "TCR2 Therapeutics Inc.": 51217, | |
| "TG Therapeutics, Inc.": 50986, | |
| "TME Pharma N.V.": 50420, | |
| "TOT BIOPHARM International Company Limited": 51498, | |
| "TRACON Pharmaceuticals, Inc.": 50748, | |
| "TScan Therapeutics, Inc.": 51427, | |
| "TWi Biotechnology, Inc.": 51102, | |
| "TaiGen Biopharmaceuticals Holdings Limited": 51069, | |
| "TaiMed Biologics Inc.": 50881, | |
| "TaiRx, Inc.": 51214, | |
| "Taiwan Liposome Company, Ltd.": 50806, | |
| "TaiwanJ Pharmaceuticals Co., Ltd.": 51198, | |
| "Takara Bio Inc.": 50556, | |
| "Talaris Therapeutics, Inc.": 51466, | |
| "Tango Therapeutics, Inc.": 51327, | |
| "Tanvex BioPharma, Inc.": 51196, | |
| "Taysha Gene Therapies, Inc.": 51519, | |
| "TegoScience Inc.": 50726, | |
| "Telix Pharmaceuticals Limited": 51353, | |
| "Telo Genomics Corp.": 51221, | |
| "Tempest Therapeutics, Inc.": 51382, | |
| "Tenax Therapeutics, Inc.": 50453, | |
| "Tenaya Therapeutics, Inc.": 51300, | |
| "Tengion, Inc.": 50632, | |
| "Thalys Medical Technology Group Corporation": 50993, | |
| "TheraVet SA": 51538, | |
| "Theralink Technologies, Inc.": 51194, | |
| "Theratechnologies Inc.": 50482, | |
| "Theriva Biologics, Inc.": 50698, | |
| "Tissue Regenix Group plc": 50739, | |
| "Tissue Repair Ltd": 51601, | |
| "Tiziana Life Sciences Ltd": 51109, | |
| "Todos Medical Ltd.": 51248, | |
| "Toleranzia AB": 51043, | |
| "Tonix Pharmaceuticals Holding Corp.": 50918, | |
| "ToolGen Incorporated": 50510, | |
| "Trans Genic Inc.": 50613, | |
| "TransCode Therapeutics, Inc.": 51370, | |
| "Transcenta Holding Limited": 51471, | |
| "Transgene Biotek Limited": 50664, | |
| "Transgene SA": 50451, | |
| "Translate Bio, Inc.": 50988, | |
| "Travere Therapeutics, Inc.": 50966, | |
| "Trevena, Inc.": 50792, | |
| "TriSalus Life Sciences, Inc.": 50945, | |
| "Trillium Therapeutics Inc.": 50649, | |
| "Turning Point Therapeutics, Inc.": 51088, | |
| "Turnstone Biologics Corp.": 51454, | |
| "Twist Bioscience Corporation": 51065, | |
| "Tyme Technologies, Inc.": 51173, | |
| "Tyra Biosciences, Inc.": 51507, | |
| "U.S. Stem Cell, Inc.": 50480, | |
| "UBI Pharma Inc.": 51240, | |
| "Ultimovacs ASA": 51061, | |
| "Ultragenyx Pharmaceutical Inc.": 50938, | |
| "Uni-Bio Science Group Limited": 50633, | |
| "UnicoCell Biomed Co., Ltd.": 51560, | |
| "Unicycive Therapeutics, Inc.": 51460, | |
| "United Therapeutics Corporation": 50399, | |
| "Unity Biotechnology, Inc.": 51241, | |
| "Univo Pharmaceuticals Ltd": 51394, | |
| "Unum Therapeutics Inc.": 51140, | |
| "UroGen Pharma Ltd.": 51057, | |
| "Urteste S.A.": 51586, | |
| "VBI Vaccines Inc.": 51175, | |
| "Vaccinex, Inc.": 50637, | |
| "Vaccitech plc": 51278, | |
| "Valbiotis SA": 51271, | |
| "ValiRx plc": 50723, | |
| "Valneva SE": 50568, | |
| "Vanda Pharmaceuticals Inc.": 50700, | |
| "Vascular Biogenics Ltd.": 50558, | |
| "Vaxart, Inc.": 50774, | |
| "Vaxcyte, Inc.": 51199, | |
| "Vaxil Bio Ltd.": 50905, | |
| "Vaxxinity, Inc.": 51574, | |
| "Vcanbio Cell & Gene Engineering Corp., Ltd": 50650, | |
| "VectivBio Holding AG": 51575, | |
| "Vectus Biosystems Limited": 51218, | |
| "Vera Therapeutics, Inc.": 51537, | |
| "Veracyte, Inc.": 50794, | |
| "Verastem, Inc.": 50935, | |
| "Vericel Corporation": 50358, | |
| "Verici Dx plc": 51518, | |
| "Vertex Pharmaceuticals Incorporated": 50400, | |
| "Verve Therapeutics, Inc.": 51469, | |
| "ViGenCell Inc.": 51429, | |
| "Vicapsys Life Sciences, Inc.": 51374, | |
| "Vicore Pharma Holding AB (publ)": 50515, | |
| "Vigil Neuroscience, Inc.": 51545, | |
| "Viking Therapeutics, Inc.": 51072, | |
| "Vincerx Pharma, Inc.": 51543, | |
| "Vir Biotechnology, Inc.": 51322, | |
| "Viracta Therapeutics, Inc.": 50778, | |
| "Viridian Therapeutics, Inc.": 50802, | |
| "Virios Therapeutics, Inc.": 51007, | |
| "Vistagen Therapeutics, Inc.": 50591, | |
| "VitaSpring Biomedical Co. Ltd.": 51324, | |
| "Vitro Biopharma, Inc.": 50493, | |
| "Vitrolife AB (publ)": 50485, | |
| "Vivesto AB": 50671, | |
| "Vivoryon Therapeutics N.V.": 50417, | |
| "Vor Biopharma Inc.": 51412, | |
| "Voronoi, Inc.": 51424, | |
| "Voyager Therapeutics, Inc.": 51100, | |
| "Vyant Bio, Inc.": 51219, | |
| "WPD Pharmaceuticals Inc.": 51462, | |
| "Walvax Biotechnology Co., Ltd.": 50856, | |
| "Waverley Pharma Inc.": 51346, | |
| "Werewolf Therapeutics, Inc.": 51397, | |
| "Willow Biosciences Inc.": 51352, | |
| "Windtree Therapeutics, Inc.": 50371, | |
| "WntResearch AB": 50928, | |
| "Wuhan Hiteck Biological Pharma Co.,Ltd": 51158, | |
| "X4 Pharmaceuticals, Inc.": 51165, | |
| "XBiotech Inc.": 51024, | |
| "XOMA Corporation": 50401, | |
| "XTL Biopharmaceuticals Ltd.": 50402, | |
| "Xbrane Biopharma AB (publ)": 50962, | |
| "Xencor, Inc.": 50481, | |
| "Xenetic Biosciences, Inc.": 50684, | |
| "Xenon Pharmaceuticals Inc.": 50466, | |
| "Xiamen Amoytop Biotech Co., Ltd.": 51041, | |
| "Xilio Therapeutics, Inc.": 51277, | |
| "Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.": 51004, | |
| "Xintela AB (publ)": 51076, | |
| "Xspray Pharma AB (publ)": 51335, | |
| "Y-mAbs Therapeutics, Inc.": 51283, | |
| "Yantai Dongcheng Pharmaceutical Group Co.,Ltd.": 50819, | |
| "Yantai Zhenghai Biotechnology Co., Ltd.": 51212, | |
| "Yield10 Bioscience, Inc.": 50560, | |
| "Yili Chuannig Biotechnology Co., Ltd.": 51492, | |
| "Yubo International Biotech Limited": 51565, | |
| "Yumanity Therapeutics Inc.": 51181, | |
| "Zai Lab Limited": 51131, | |
| "Zealand Pharma A/S": 50507, | |
| "Zenith Capital Corp.": 51059, | |
| "Zenotech Laboratories Limited": 50666, | |
| "Zentalis Pharmaceuticals, Inc.": 51503, | |
| "Zhejiang Orient Gene Biotech Co., Ltd.": 51496, | |
| "ZyVersa Therapeutics, Inc.": 51126, | |
| "Zymeworks Inc.": 50797, | |
| "aTyr Pharma, Inc.": 50749, | |
| "argenx SE": 50862, | |
| "bioAffinity Technologies, Inc.": 51325, | |
| "bluebird bio, Inc.": 50376, | |
| "co.don AG": 50422, | |
| "e-therapeutics plc": 50685, | |
| "eFFECTOR Therapeutics, Inc.": 51055, | |
| "genOway Société anonyme": 50414, | |
| "genXone S.A.": 51428, | |
| "iBio, Inc.": 50394, | |
| "iTeos Therapeutics, Inc.": 51516, | |
| "uniQure N.V.": 50996, | |
| "vTv Therapeutics Inc.": 51191 | |
| } | |